What is the appropriate hydrocortisone dose for an acute asthma exacerbation in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydrocortisone Dose for Acute Asthma Exacerbation

For acute asthma exacerbations, use hydrocortisone 200 mg IV (approximately 4 mg/kg) initially in adults, or alternatively use oral prednisone 40-80 mg/day, as there is no advantage to higher doses or IV over oral administration when GI absorption is intact.

Dosing Recommendations

Adults

  • Initial IV dose: 100-500 mg hydrocortisone, with 200 mg being a reasonable starting point 1
  • Maintenance: Repeat every 4-6 hours as needed based on clinical response 1
  • Oral alternative (preferred): Prednisone 40-80 mg/day in 1-2 divided doses until PEF reaches 70% of predicted 2
  • Duration: 5-10 days total; no taper needed for courses <1 week 2

Children (<12 years)

  • IV hydrocortisone: 0.56-8 mg/kg/day in 3-4 divided doses (20-240 mg/m²/day) 1
  • Oral alternative (preferred): Prednisone 1-2 mg/kg/day (maximum 60 mg/day) in 2 divided doses 2
  • Duration: 3-10 days; no taper needed for short courses 2

Critical Evidence-Based Principles

No advantage to higher doses: Multiple high-quality studies demonstrate that low-dose corticosteroids (≤80 mg/day methylprednisolone equivalent or ≤400 mg/day hydrocortisone) are as effective as higher doses 3, 4. A Cochrane review found no clinically significant differences in FEV1 recovery at 24,48, or 72 hours between low, medium, and high doses 3.

Oral equals IV when GI intact: The NAEPP guidelines explicitly state there is no advantage for IV administration over oral therapy when gastrointestinal transit time or absorption is not impaired 2. This is a crucial point—reserve IV for patients who are vomiting or have severe respiratory distress preventing oral intake.

Practical Administration

Route Selection Algorithm

  1. Patient can swallow and not vomiting → Use oral prednisone (easier, equally effective)
  2. Vomiting, severe distress, or NPO → Use IV hydrocortisone
  3. After initial stabilization (48-72 hours) → Switch to oral formulation 1

Dosing Equivalents

For comparison purposes (oral/IV administration):

  • Hydrocortisone 400 mg = Methylprednisolone 80 mg = Prednisone 100 mg (approximately)

Important Caveats

High-dose therapy duration: If using high-dose hydrocortisone IV, limit to 48-72 hours maximum due to risk of hypernatremia 1. Beyond this timeframe, consider switching to methylprednisolone which causes less sodium retention.

Pediatric considerations: Research shows 1 mg/kg/day prednisolone is non-inferior to 2 mg/kg/day in preschool children with moderate exacerbations, with significantly less vomiting 5. Start at the lower end of the dosing range when appropriate.

No benefit to early IV steroids: One study found that early administration of 500 mg IV hydrocortisone in the ED did not modify outcomes or improve pulmonary function in the first 6 hours when aggressive beta-agonist therapy was used 6. This suggests steroids can be given orally from the start in most cases.

Comparison of IV steroids: Recent pediatric data shows IV methylprednisolone, hydrocortisone, and dexamethasone have equivalent efficacy when dosed appropriately 7. Choose based on availability and institutional preference.

Monitoring and Adjustment

  • Continue until PEF reaches 70% of predicted or personal best 2
  • Reassess every 4-6 hours initially
  • Begin inhaled corticosteroids at any point during treatment 2
  • No taper required for courses ≤10 days, especially if patient is on inhaled corticosteroids 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.